Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Biotech Startup Turns to Space to Manufacture Artificial Retinas for Treating Blindness

A biotechnology startup is harnessing the unique space environment to manufacture artificial retinas that could one day restore vision to the millions of people blinded by macular degeneration.

13 Jun 2026

Collagen Exists as Liquid-Like Droplets Inside Cells

According to a recent study from the Centre for Genomic Regulation (CRG) in Barcelona, collagen, the protein that forms skin, bones, tendons, and organs, occurs inside cells as a liquid-like droplet rather than the long, rigid rod portrayed in textbooks during the past fifty years.

12 Jun 2026

AI Reducing Animal Testing, Speeding Drug Trials

Brisbane biotech company Gelomics is helping advance a new generation of drug development through its platform for creating lab-grown human tissue models, giving researchers a more human-relevant way to test compounds in early-stage research without relying on animal experiments.

11 Jun 2026

Microbes Reveal Missing Link in Space Manufacturing

Manufacturing materials in space may hinge on a simple problem: feeding microbes.

5 Jun 2026

Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated workflow for the characterization of charge and size variants in bispecific antibodies and biosimilars.

From Bio-Techne 4 Jun 2026

How a Tiny Bacterial Enzyme Could Clean Up Chemical Manufacturing

Industrial oxidation chemistry is a cornerstone of modern manufacturing, accounting for nearly one-third of all chemical industrial processes.

3 Jun 2026

M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy

Maculaser Oy, a Finland-based medtech company developing a first-of-its-kind temperature-controlled retinal laser therapy, announces a new undisclosed investment with the participation of M2care, a European healthtech venture studio, and ZEISS Ventures, the corporate venture capital arm of the ZEISS Group.

29 May 2026

ION Secures First Global Partners, Advancing Australia's Next Generation of Life Sciences Innovation

Sydney's life sciences sector has reached a major milestone, with Kurraba Group announcing the first confirmed partners for ION – a purpose-built commercial life sciences precinct set to redefine innovation infrastructure in Australia.

From ION 25 May 2026

Polymer Platforms Help Focus Immune Attack on Cancerous Tumors

Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but typically benefit less than 30% of patients.

21 May 2026

Insects, Microbes, and Food Waste May Be the Answer to the Global Food Crisis

This review examines how minimally processed foods, plant-based alternatives, functional foods, novel protein sources, and food waste valorization could help build healthier and more sustainable food systems. It highlights their potential to improve nutrition, reduce environmental pressures, and strengthen food security, while noting barriers around cost, regulation, safety, labelling, scalability, and consumer acceptance.

19 May 2026

Twisted Light Breakthrough Could Enable Earlier Disease Detection

Researchers from the Australian Research Council Centre of Excellence in Optical Microcombs for Breakthrough Science (COMBS) have developed a powerful new way to use light to measure tiny changes in biological fluids such as blood – using samples as small as a millionth of a drop.

12 May 2026

Advances in DNA Assembly Enable Efficient Microbial Cell Factories

A review in Quantitative Biology demonstrates that scientists can now reliably build and combine very large pieces of DNA, making it much easier to redesign microbes such as yeast and bacteria to act as efficient "cell factories."

7 May 2026

CapyBio Launches New Analysis Services to Improve Cell Identity Engineering

CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ Differentiation Optimization Analysis.

7 May 2026

Gene Editing Reprograms Immune System to Produce Therapeutic Proteins

An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins-including certain kinds of highly potent antibodies the are naturally difficult to produce-by reprogramming the immune system itself.

20 Apr 2026

AI Predicts Viral Mutations to Design Future-Proof Vaccines

The wave-shaped chart Ratul Chowdhury pulls up on a computer monitor in his office captures the evolutionary cat-and-mouse game his research lab is up against.

13 Apr 2026

Semen-Derived Exosomes Eye Drops to Treat Retinoblastoma

Innovative eye drops using semen-derived exosomes target retinoblastoma, improving therapeutic delivery and preserving ocular function in preclinical models.

8 Apr 2026

Regenerative Vascular Grafts Solve Key Shortage In Surgery

Engineered biotubes demonstrate strong mechanical performance and rapid tissue regeneration, offering a scalable solution to the vascular graft shortage.

2 Apr 2026

PRISM ALS: New Stem Cell Models Could Transform Research into Treatments for MND/ALS

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current cell models used for testing treatments do not currently reflect the diverse nature of the disease – that affects both researchers developing therapies and the people urgently waiting for them.

From Axol Bioscience Ltd 2 Apr 2026